Integration of Hydrogen–Deuterium Exchange Mass Spectrometry with Molecular Dynamics Simulations and Ensemble Reweighting Enables High Resolution Protein–Ligand Modeling
- 10 September 2024
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of the American Society for Mass Spectrometry
- Vol. 35 (11) , 2714-2728
Abstract
Hydrogen-Deuterium exchange mass spectrometry's (HDX-MS) utility in identifying and characterizing protein-small molecule interaction sites has been established. The regions that are seen to be protected from exchange upon ligand binding indicate regions that may be interacting with the ligand, giving a qualitative understanding of the ligand binding pocket. However, quantitatively deriving an accurate high-resolution structure of the protein-ligand complex from the HDX-MS data remains a challenge, often limiting its use in applications such as small molecule drug design. Recent efforts have focused on the development of methods to quantitatively model Hydrogen-Deuterium exchange (HDX) data from computationally modeled structures to garner atomic level insights from peptide-level resolution HDX-MS. One such method, HDX ensemble reweighting (HDXer), employs maximum entropy reweighting of simulated HDX data to experimental HDX-MS to model structural ensembles. In this study, we implement and validate a workflow which quantitatively leverages HDX-MS data to accurately model protein-small molecule ligand interactions. To that end, we employ a strategy combining computational protein-ligand docking, molecular dynamics simulations, HDXer, and dimensional reduction and clustering approaches to extract high-resolution drug binding poses that most accurately conform with HDX-MS data. We apply this workflow to model the interaction of ERK2 and FosA with small molecule compounds and inhibitors they are known to bind. In five out of six of the protein-ligand pairs tested, the HDX derived protein-ligand complexes result in a ligand root-mean-square deviation (RMSD) within 2.5 Å of the known crystal structure ligand.Keywords
Funding Information
- University of Maryland, Baltimore (SOP1841-IQB2014)
- National Institute of General Medical Sciences (T32 GM066706)
This publication has 81 references indexed in Scilit:
- Integrating Molecular Simulation and Experimental Data: A Bayesian/Maximum Entropy Reweighting Approach2020
- Simulated Isotope Exchange Patterns Enable Protein Structure DeterminationAngewandte Chemie International Edition, 2017
- CHARMM-GUI ligand reader and modeler for CHARMM force field generation of small moleculesJournal of Computational Chemistry, 2017
- Fast docking using the CHARMM force field with EADock DSSJournal of Computational Chemistry, 2011
- Blind docking of pharmaceutically relevant compounds using RosettaLigandProtein Science, 2009
- AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreadingJournal of Computational Chemistry, 2009
- CHARMM‐GUI: A web‐based graphical user interface for CHARMMJournal of Computational Chemistry, 2008
- ROSETTALIGAND: Protein–small molecule docking with full side‐chain flexibilityProteins: Structure, Function, and Bioinformatics, 2006
- Application and Limitations of X‐ray Crystallographic Data in Structure‐Based Ligand and Drug DesignAngewandte Chemie International Edition, 2003
- Primary structure effects on peptide group hydrogen exchangeProteins: Structure, Function, and Bioinformatics, 1993